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ABSTRACT 
Amlapitta is one of the leading problems of new era due to irregular and improper diet, dietetics 
and stressful life style. It is a very common disorder of Annavahasrotasa caused by Vidagdha Pitta 
with features like, Abipaka (indigestion), Klama (fatigue), Utklesha (nausea), Tikta-Amlodgara 
(sour or bitter eructation), Gourava (heaviness), Hritkanthadaha (heart burn), Aruchi (anorexia) 
etc., Amlapitta include acid peptic disorders (APD)- gastroesophageal reflux disease (GERD), 
Peptic ulcer diseases (PUD), dyspepsia and functional disorder of GI tract, In the present study, 
aimed to compare the efficacy of Jeerakadya Ghrita Arohanakrama Snehapana (increasing order) 
followed by Virechana with Trivrit Churnaadi yoga and Patolashunti Ghrita Arohanakrama 
Snehapana followed by Virechana with Trivritchurnadi yoga in the management of Adhoga 
Amlapitta. Material and methods: A minimum of 30 patients suffering from Adhoga Amlapitta were 
selected in 2 groups, 15 patients in each group. Group A- 15 patients were given Jeerakadya Ghrita 
Arohanakramasnehapana and Virechana. Group B-15 patients were given Patolashunti Ghrita 
Arohanakramasnehapana and Virechana. Follow up for 14 days (Patients will be assessed clinically 
on day 0, 7th day & 14th day). Total study duration is 35days. Virechana is highly significant on all 
the parameters, except Bhrama at both the phases. Statistical analysis of Group A and Group B are 
showing same result, but there will be reduction percentage in sign and symptoms like Agnimagda, 
Trishna, Hrillasa, Bhrama, Vividhavarnayoukta Malapravritti Group A is given better result. 
KEYWORDS: Adhoga Amlapitta, Arohanakrama Snehapana, Virechana, Jeerakadya Ghrita, 
Patolashunti Ghrita. 
INTRODUCTION 
Amlapitta is one of the leading problems of 
new era due to irregular and improper diet and 
dietetics and stressful life style, it altered the 
physiology of our digestion. It is a very common 
disorder of Annavahasrotasa caused by Vidagdha 
Pitta with features like, Abipaka (indigestion), Klama 
(fatigue), Utklesha (nausea), Tikta-Amlodgara (sour 
or bitter eructation), Gourava (heaviness), 
Hritkanthadaha (heart burn), Aruchi (anorexia) etc.[1] 
It classify into two head.[2] In case of Adhoga 
Amlapitta, Tritshna (thirst), Daha (burning 
sensation), Murcha (fainting), Bhrama (vertigo), 
Moha (delusion), Hrillus (nausea), Kotha (urticaria), 
Analsad (suppressed digestion), Romaharsa 
(horripilation), Sveda (sweating), Angapitwata 
(yellow discoloration of the body).[2] This condition is 
found very rear, whereas Urdhaga Amlapitta is 
characterized by Chardhi (vomiting), where vomit us 
is multiple in colored and sour or bitter in taste. It 
may be associated with sour or bitter belching. 
Person vomits during digestion of food or in empty 
stomach. Burning sensation in the throat, chest, and 
upper abdomen, headache, burning sensation in the 
palms and sole, loss of appetite, skin rashes, itching 
and skin problem also found.[3] Amlapitta include 
Acid Peptic Disorders (APD)- gastroesophageal reflux 
disease (GERD), Peptic ulcer diseases (PUD), 
dyspepsia and functional disorder of GI tract. APD 
can affect esophagus, stomach, and duodenum. ADP 
has varied presentation due to overlapping 
pathogenic mechanisms which could lead to 
excessive acid secretion or diminished mucosal 
defense.[4] Although currently available 
pharmacologic approaches can successfully control 
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the aforesaid sign and symptoms but there is still a 
serious need for novel therapy that will simplify 
treatment regimens and improve quality of life. In 
modern medicine, plenty of new drugs are being 
explored to manage these types of problems but no 
permanent cure is achieved in most of the cases 
except symptomatic relief up to some extent. 
Sometime adverse effects of the modern medicine are 
also seen when administered for longer duration. 
Nowadays due to changing life style and food habits 
Amlapitta is becoming a very dreadful disorder and 
leading to several complications. A population based 
study, using a validated questionnaire, found that 
58.7% of the population has heartburn or acid 
regurgitation at least once during the course of a year 
and that 19.8% experience symptoms at least once 
weekly.[5] It is estimated that approximately 50% of 
patients with typical reflux symptoms have erosive 
esophagitis and very often no abnormality is 
discovered during investigations especially in 
younger patients [<40 years of age]. Aacharyas have 
mentioned that, in the management of Amlapitta, 
Vamana and Virechana are the main line of Shodhana 
modalities followed by Langhana, Laghu Bhojana and 
Agnideepana measures needs to be adopted.[6] 
Acharya Bhabmishra mentioned Vamana in 
Urdhwanga Amlapitta and virechana in Adhoga 
Amlapitta.[7] Hence in the present study, minimum of 
30 diagnosed Adhoga Amlapitta patients were 
selected to assess the “Evaluation of Efficacy of 
Arohanakrama Snehapana and Virechana in the 
management of Adhoga Amlapitta”. 
 
 
MATERIALS AND METHODS 
Study design: A Simple comparative clinical 
prospective study and sampling technique is 
purposive or deliberate. 
Sample size and grouping: A minimum of 30 
patients suffering from Adhoga Amlapitta were 
selected in 2 groups, 15 patients in each group. Group 
A- 15 patients were received Jeerakadya Ghrita[8-10] 
Arohanakrama snehapana and Virechana. Group B-15 
patients received Patolashunti Ghrita[11-13] Arohana-
kramasnehapana and Virechana. 
Source of Data: Patients suffering from Adhoga 
Amlapitta were selected from O.P.D and I.P.D. of 
D.G.M.A.M.C & Hospital, Gadag after fulfilling the 
inclusion and exclusion criteria. 
Inclusion Criteria 
Presence of clinical features of Audhoga 
Amlapitta like Agnimandya, Daha, Trishna, Hrillasa, 
Bhrama, vividha varnayouktamala pravritti. 
Age group between 20 to 60 years of both 
genders. Patient who is fit for Arohanakrama (gradual 
increasing order) Snehapana and Virechanakarma. 
Exclusion Criteria 
 Patients with history of systemic illness like 
Diabetic mellitus and Hypertension, Endocrine 
disorder, Cardiac pathology, Immune deficiency 
disorders like AIDS. 
 Patients with history of Parinama Shula 
(gastric ulcer), Annadrava Shula (duodenal ulcer), 
Krimiroga (worm disease), Arbuda (lump), Grahani 
(I.B.S.) etc. Patient with history of haemetmesis, 
maleana and anemia. Patients with drug induced 
Amlapitta. 
Study design:  
 Purvakarma Pradhanakarma Paschatkarma 
Group A Jeerakachurna For Deepana-Pachana:3 
days. 
Trivritchurnadivirechanayoga1




to suddhi) Jeerakadya Ghrita for Arohanakarma. 
Snehapana :-3-7days 
Moorchita Tilataila for Sarvanga 
Abhyanga before virechana:3days 
Group B 
 






Patolasunthi Ghrita for 
Arohanakarmasnehapana:-3-7days 
Moorchita Tilataila for Sarvanga 
Abhyanga before Virechana :3days 
Follow up 14 days (Patients will be assessed clinically on day 0, 7th day & 14thday). Total study duration 35days. 
Assessment criteria 
 Assessment will be done by considering the base line of data of subjective parameters to pre and post 
medication and will be compared for assessment of result. All the results will be analyzed statistically for p 
value using un-paired t-test. 
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Assessment grading 
S.No. Symptom Grade Observation 
1. Agnimanda 0 Normal 
1 Digest liquid food 
2 Digest liquid food with difficulty 
3 Digest normal food with difficulty 
4 Unable to digest normal food  
2. Daha 0 Daha absent 
1 Occasional present 
2 Once in a week present 
3 2-3 day in a week present 
4 Daily present 
3. Trishna 0 Trishna normal 
1 Mild and tolerable 
2 Moderate and tolerable 
3 Severe relived by milk and water 
4 Not relived by any measure  
4. Hrillas 0 Hrillas absent 
1 Occasional present 
2 Once in a week present 
3 2-3 day in a week present 
4 Daily present 
5. Bhrama (vertigo) 
 
0 Bhrama absent 
1 Occasional present 
2 Once in a week present 
3 2-3 day in a week present 
4 Daily present 




0 Vividha Varna Yukta Malapravritti absent 
1 Occasional present 
2 Once in a week present 
3 2-3 day in a week present 
4 Daily present 
Investigations: For diagnostic purpose 
HB%, Total WBC count, Differential count, ESR, RBS, 
Stool examination (if necessary). 
Data Collection: Patients were thoroughly examined 
both subjectively. Detailed history pertaining to the 
mode of onset, previous ailment, previous treatment 
history, family history, habits, routine investigations 
and radiological features are also investigated to 
exclude other pathologies. 
Observation and Results 
30 patients of Adhoga Amlapitta fulfilling the 
criteria for diagnosis were treated in two groups 
along with validation of disease state.  
Demographic Data 
Distribution of Patients as per Age: Among 30 
patients, 18 patients i.e., 60% were of 20-30 age 
group, 5 patients i.e., 16.67% were of 30-40 age 
group, 4 patients i.e., 13.33% were of 40-50 age 
group, 3 patients i.e., 10% were of 50-60 age group. 
Distribution of Patients as per Sex: Among 30 
patients 21 patients i.e., 70% were males and females 
were 9 patients i.e., 30%. 
Distribution of Patients as per Religion: Among 30 
patients 27 patients i.e., 90% patients were Hindus, 3 
patients i.e., 10% patients were Muslims. 
Distribution of Patients as per Occupation: Among 
30 patients 25 patients i.e., 83% were active, 3 
patient’s i.e., 10% were labor and 2 patients i.e., 
6.67% were sedentary work. 
Distribution of Patients as per Socio-economic 
Status: Among 30 patients 4 patients i.e., 13.33% 
were poor and 11 patients i.e., 36.67% were middle 
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class and 10 patients i.e., 33.33% were higher middle 
class, 5 patients i.e., 16.67% were higher class. 
Distribution of Patients as per Marital Status 
Among 30 patients 14 patients i.e., 46.67% 
were married, 16 patients i.e., 53.33% were 
unmarried. 
Data related personal status 
Distribution of patients based on Prakriti 
 Among 30 patients 16 patients i.e., 53.33% 
were Vata-Pitta Prakriti, 10 patients i.e., 33.33% 
were Vata-Kapha Prakriti and 4 patients i.e., 13.33% 
were Pitta- Kapha Prakriti. 
Distribution of patients based on Jathar Agni 
 Among 30 patients 15 patients i.e., 50% were 
Manda Jatharagni, no patient was 
TeekshnaJatharagni, 15 patients i.e., 50% were 
VishamaJathar Agni and no patient was Samaagni. 
Distribution of patients based on Koshtha 
 Among 30 patients 14 patients i.e., 46.67% 
were Mridu Koshtha, 4 patients i.e., 13.33% were 
Madhyama Koshtha and 12 patients i.e., 40% were 
Krurakostha. 
Distribution of patients based on Addiction 
 Among 30 patients, 10 patients i.e., 33.33% 
had the habit of Alcohol, 9 patients i.e., 30% had the 
habit of smoking, 6 patients i.e., 20% had the habit of 
tobacco, 30 patient’s i.e., 100% had the habit of tea 
and 29 patients i.e., 96.67% had the habit of coffee. 
Distribution of patients based on Diet 
Among 30 patients, 14 patients i.e., 46.67% 
were vegetarian, 16 patients i.e., 53.33% were mixed 
diet. 
Distribution of patients based on incidence of 
Nidra: Among 30 patients 21 patients i.e., 70% had 
normal sleep, 9 patients i.e., 30% had disturbed sleep. 
Distribution of patients based on Manasika 
Avastha: Among 30 patients 21 patients i.e., 70% had 
Bhaya, 24 patients i.e., 80% had Kopa, 10 patients i.e., 
33.33% had Mada, 21 patients i.e., 70% had Udvega, 
24 patients i.e., 80% had Deenata, 17 patients i.e., 
56.67% had Samprahara and 16 patients i.e., 53.33% 
had Kshobha. 
Distribution of patients based on Aggravating 
factor: Among 30 patients the predominant 
aggravating factors were all patients i.e., 100% spicy 
food, 30 patients i.e., 100% mental stress, 12 patients 
i.e., 40% depression, 26 patients i.e., 86.67% fasting, 




Distribution of patients based on Relieving factor 
Among 30 patients the predominant 
Relieving factor were 17 patients i.e., 56.67% relieve 
by food intake, 30 patients i.e., 100% relieve by 
Antacids, 22 patients i.e., 73.33% relieve by rest, 7 
patients i.e., 23.33% relieve by fasting, 27 patients 
i.e., 90% relieve by H2 blocker, one patient i.e., 3.33% 
relived by other factor. 
Distribution of patients based on Aharaja Nidana 
Among 30 patients the Aharaja Nidana, 25 
patients i.e., 83.33% use to take Virudhaahara, 28 
patients i.e., 93.33% use to take Dushta, 29 patients 
i.e., 96.67% use to take Amla and Pitta 
vardhakasahara, 17 patients i.e., 56.67% use to take 
Vidahiahara. 
Data related to incidence of Viharaja Nidana 
 Among 30 patients the Viharaja Nidana, 9 
patients i.e., 30% use to take Dhoomrapana, 16 
patients i.e., 53.33% used Aatapa Sevana, 23 patients 
i.e., 76.67% used Ratrijagaran 4 patients i.e., 
13.337% used Atimaithuna, 17 patients i.e., 56.67% 
used Parishram and Vegadharan 9 patients i.e., 30% 
used to take Madya, 3 patients i.e., 10% use to take 
Avagaha, 17 patients i.e., 56.67% Adhogaamlapitta 
aggravate according to Ritu. 
Data related to incidence of Pradhana Vedana 
 Among 30 patients the Pradhana 
Vedana, 28 patients i.e., 9.33% came with Hrillasa, all 
patients i.e., 100% came with complain of Kantha 
Daha and Agnimandya, 29 patients i.e., 96.67% came 
with Trishna, 10 patients i.e., 33.33% came with 
complain of Bhrama, 26 patients i.e., 86.67% came 
with complain of Vividha varna yukta malapravritti. 
Data related to incidence of Anubandha Vedana 
 Among 30 patients the Anubandha Vedana, 23 
patients i.e., 76.67% came with complain of 
Udarashoola, 8 patients i.e., 26.67% came with 
Adhmana, 3 patients i.e., 10% came with complain of 
Atisara, 14 patients i.e., 46.67% came with complain 
of Romaharsha, 24 patients i.e., 80% came with 
complain of Aantrakujana. 
Data related to incidence Chronicity of Disease 
 Among 30 patients 19 patients i.e., 63.33% 
had chronicity of disease<6month, 6 patients i.e., 
20% had >6 month chronic and 5 patients i.e., 
16.67% had>12month chronic of Adhoga Amlapitta. 
Data related to incidence Overall response 
 Among 30 patients 10 patients i.e., 
33.33% were well responded, 12 patients 40% were 
moderately responded and 8 patients i.e., 26.67% 
responded in Adhoga Amlapitta. 
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Table 1: Showing Data related to statistical analysis of Group A 
 n Mean Reduction % SD SE t-test P 
B.T. AT 
Agnimanda 15 3.6 0.5333 85.18 0.703 0.187 16.87738 < 0.001 
Kantha Daha 15 4.00 0.6 85 0.50709 0.135 25.968 < 0.001 
Trishna 15 2.133 0.267 87.48 0.6399 0.171 11.297 < 0.001 
Hrillasa 15 3.13 0.516 83.51 1.12 0.2996 8.98 < 0.001 
Bhrama 15 1.0 0.2667 73.33 1.099 0.2937 2.582 0.0217 
Vividhavarnayuktamal
apravritti 
15 2.4 0.667 72.2 1.437 0.384 4.669 < 0.001 
SD=Stander deviation, SE=stander error, AT=after treatment, BT=before treatment 
Table 2: Showing Data related to Statistical Analysis of Group B 
 n Mean Reduction on 
% 
SD SE t p 
B.T. AF   
Agnimanda 15 3.8 0.6667 82.45 0.743 0.198 16.328 < 0.001 
Kantha Daha 15 4.00 0.2667 93 0.703 0.188 20.546 < 0.001 
Trishna 15 2.8 0.5333 80.95 0.798 0.213 10.989 < 0.001 
Hrillasa 15 2.8 0.6 78.57 1.08 0.289 7.872 < 0.001 
Bhrama 15 0.26 0.0667 74.99 0.56 0.149 1.3817 0.1887 
Vividhavarna 
yuktamalapravritti 
15 2.33 0.6 74.15 1.032 0.276 6.5 < 0.001 
SD=Stander deviation, SE=stander error, AT=after treatment, BT=before treatment
Distribution of patients based on Agnimandya: In 
Group-A before treatment mean was 3.6 and after 
follow up mean was 0.533 and percentage of 
reduction 85.18, which was highly significant at the 
level of P<0.001. In Group-B before treatment mean 
was 3.8 and after follow up mean was 0.667 and 
percentage of reduction 82.45, which was highly 
significant at the level of P<0.001. 
Distribution of patients based on Kantha Daha: 
In Group-A before treatment mean was 4 and after 
follow up mean was 0.6 and percentage of reduction 
85, which was highly significant at the level of 
P<0.001. In Group-B before treatment mean was 4.0 
and after follow up mean was 0.2667 and percentage 
of reduction 93.00, which was highly significant at 
the level of P<0.001. 
Distribution of patients based on Trishna: In 
Group-A before treatment mean was 2.133 and after 
follow up mean was 0.267 and percentage of 
reduction 87.48, which was highly significant at the 
level of P<0.001. In group-B before treatment mean 
was 2.8 and after follow up mean was 0.533 and 
percentage of reduction 80.95, which was highly 
significant at the level of P<0.001. 
Distribution of patients based on Hrillasa: In 
Group-A before treatment mean was 3.13 and after 
follow up mean was 0.516 and percentage of 
reduction 83.15, which was highly significant at the 
level of P<0.001. In Group-B before treatment mean 
was 2.8 and after follow up mean was 0.6 and 
percentage of reduction 78.57, which was highly 
significant at the level of P<0.001. 
Distribution of patients based on Bhrama: In 
Group-A before treatment mean was 1.00 and after 
follow up mean was 0.2667 and percentage of 
reduction 73.33, which was highly significant at the 
level of P=0.0217. In Group-B before treatment 
mean was 0.266 and after follow up mean was 
0.067 and percentage of reduction 74.99, which was 
highly significant at the level of P=0.1887. 
Distribution of patients based on Vividha-
varnayuktamalapravritti: In Group-A before 
treatment mean was 2.4 and after follow up mean 
was 0.667 and percentage of reduction 72.2, which 
was highly significant at the level of P<0.001. In 
Group-B before treatment mean was 2.33 and after 
follow up mean was 0.6 and percentage of 
reduction 74.15, which was highly significant at the 
level of P<0.001. 
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DISCUSSION 
In the present clinical study 33 patients were 
reported from OPD and IPD of Sri. D.G.M. Ayurveda 
College, Hospital. 3 patients were dropped out in 
various stages of clinical study and rest 30 patients 
were fulfilling the criteria of inclusion and exclusion. 
Discussion on Virechana: Inclusion 30 patients 
averagely 10 Vegas occurred, maximum 26 Vega and 
minimum 4 Vega occurred, but 27 patients were 
vomiting this yoga within 10- 15minuts after intake 
of the Yoga 1-2 times, because Trivrit is Katu, Tikta, 
Madhura, Kashaya with Amla rasa for 
Amalakikashaya also with Madhu which is Madhura 
and Kashaya rasa combination of those drugs it Yoga 
made waste in test. Amla rasa increased salivation 
that’s why may be vomiting. Virechana karma 
approximately averagely output was 1400ml; most of 
the patients show Kaphaantaki Virechana. 
DISCUSSION ON RESULTS 
Effect of medicine on Assessment Criteria: The 
criteria taken for assessment were Agnimanda, 
Kantha daha, Trishna, Hrillasa, Bhrama, 
Bividhavarnayoukta Malapravritti. Statistical analysis 
showed that the effect of medicine was highly 
significant on all the parameters, except Bhrama at 
both the phases. 
Effect of medicine on Agnimanda: According to 
statistical analysis, Group A and Group B both group 
individually are significant, reduced Agnimanda. But 
in both group A improvement was 85% and group B 
improvement was 82.45%, so group A is more 
effective than group B. 
Effect of medicine on Kantha Daha: According to 
statistical analysis, group A and group B both group 
individually are significant, reduced Kantha Daha. But 
in both group A improvement was 85% and Group B 
improvement was 93%, so group B is more effective 
than group A. 
Effect of medicine on Trishna: According to 
statistical analysis, group A and group B both group 
individually are significant, reduced Trishna. But in 
both group A improvement was 87.5% and Group B 
improvement was 80.95%, so group A is more 
effective than group B. 
Effect of medicine on Hrilasa: According to 
statistical analysis, group A and group B both group 
individually are significant, reduced Hrilasa. But in 
both group A improvement was 82.9% and group B 
improvement was 78.57%, so group A is more 
effective than group B. 
Effect of medicine on Bhrama: According to 
statistical analysis, group A and group B both group 
individually are not significant, reduced Bhrama. But 
in group A improvement was 73.33% and Group B 
improvement was 75%, so group B is more effective 
than group A. 
Effect of medicine on Vividha varna 
yuktamalapravritti: According to statistical analysis, 
group A and group B both group individually are not 
significant, reduced Vividha varna yuktamalapravritti. 
But in group A improvement was 72.22% and group 
B improvement was 74.28%, so group B is more 
effective than group A. 
Overall Effect of Medicine: Among the 30 patients 
treated, 10(33.33%) patients well responded, 12 
(40%) patients moderately responded, whereas 8 
(26.67%) patients mild responded. There are no 
patients who poorly responded or not responded. 
Amlapitta being a disease where there are chances of 
recurrence are there, Shodhana played major role in 
reducing recurrence rate. Even though, all the 
parameters did not show complete relief, though 
intensity was reduced patients continued with few 
complaints. That is mainly because, some patients 
were not able to follow the Pathya, because of their 
nature of work, circumstances and even because of 
season. 
Effect of Therapy 
Comparative Effects of Treatment in Group A & 
Group B 
Table 3: Showing the comparative effect of treatment on Assessment criteria in Group A and Group B 
 Group A Group B SE t p Remarks 
n Mean S.D n Mean S.D. 
Agnimanda 15 3.0 0.70 15 3.13 0.74 0.264 0.276 >0.05 NS 
Kantha Daha 15 2.8 0.86 15 3.73 0.70 0.287 3.24 <0.01 HS 
Trishna 15 1.8 0.63 15 2.26 0.79 0.263 1.541 >0.05 NS 
Hrillasa 15 2.6 1.12 15 2.2 1.08 0.401 0.995 >0.05 NS 
Bhrama 15 0.7 1.09 15 0.2 0.56 0.318 1.673 >0.05 NS 
V.V. Y. M 15 1.7 1.43 15 1.73 1.03 0.475 0.006 >0.05 NS 
To compare the assessment result of the 
treatment procedure between the two groups, the 
statistical analyses is done by using Un-paired t-test, 
by assuming that the mean effect treatment 
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procedures is same in both the groups after 
treatment procedure. From the analyses, it is clear 
that only the parameters Kanthadaha highly 
significant result respectively. Remaining all the 
factors went not significant statistically. 
Mode of action of Virechana Karma: Ayurveda 
gives much importance to Shodhana Chikitsa. The 
importance of Shodhana is explained as 
“Napunarudbhavet” which means, when the disease is 
treated with Shodhana there are no chances of 
recurrence The Ashaya (site) involved in this disease 
Amashaya and upper end of Pakvashaya. The Dosha 
involved is mainly Pitta, which includes the Pachaka 
Pitta of Amashaya and the Dushyais Rasa and Rakta 
Dhatu. Considering these entire factor it was tried to 
give Virechana to remove the vitiated Dosha, which is 
having an ideal cleansing action on Pitta. The process 
of Virechana may be able to expel the excessive 
Dravata (liquidity) of Pitta and Pitta present in rest of 
Avayavas can be eliminated out. Rasa Dushti can be 
corrected by this process. After the process of 
Virechana, the Agni, digestive power is increased so it 
is beneficial for further digestion. After Shodhana 
patient usually felt lightness. The active ingredients 
of the given medicine will stimulate the mucosal 
membrane and changes the normal permeability of 
mucosal lining temporarily, due to which exudation 
of morbid impurities which were transferred from 
cellular level to gut level with the help of Snehana 
and Swedana karma are expelled out through Anal 
route. Even just after Virechana process there is 
reduction in severity of symptoms.  
CONCLUSION 
From this study it can be concluded that 
alteration of diet and dietetic rule (junk food, alcohols 
and tobacco), behavior (stressful late night work, 
suppression of natural urges) plays a major role in 
causation disease Amlapitta. The psychological factor 
stress and strain of this present era are related with 
the pathogenesis of this disease. Amlapitta is result of 
Agnidushti and it is chronic in nature and difficult to 
cure. Rasa and Rakta are involved as Dushya and 
Rasavaha, Raktavaha, Annavaha and Purishavaha 
Srotasa is involved. All the classical symptoms of 
Audhoga Amlapitta manifested clearly, but Bhrama is 
rare symptoms, it is manifestation in chronic 
condition. Virechana is very effective in the 
management of Adhoga Amlapitta. It also avoids the 
early relapses as it eliminates the Dosha out of the 
body. It shows good result in Dhatugata Avastha of 
Audhoga Amlapitta. 
The drugs Jeerakadya Ghrita and Patolasunthi 
Ghrita were effective in Amlapitta. Arohanakrama 
(increasing order) Snehapana took major role to 
Shodhana as Doshautkleshana. The cardinal 
symptoms are reduced Arohanakramasnehapana 
ongoing. It was observed that the Shodhana is 
specifically effective in early cases of Amlapitta. This 
beneficial effect of trial drug may be due to Tikta 
Rasa, Laghu, Ruksha property and Kapha-pittahara 
action of the combined drug. In chronic condition 
may takes repeated Shodhana to control the disease. 
Virechana is highly significant on all the parameters, 
except Bhrama at both the phases. Statistical analysis 
Group A and Group B are showing same result, but 
there will be reduction percentage in sign and 
symptoms like Agnimagda, Trishna, Hrillasa, Bhrama, 
Vividhavarnayoukta Malapravritti Group A is given 
better result. 
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